TMO Financial Facts
Cost of service revenues: 412.7MTotal costs and operating expenses: 3.95B
See Full Income Statement
Other current assets: 948.4M
Total shareholders' equity: 21.66B
See Full Balance Sheet
Thermo Fisher Scientific, Inc. (TMO) Earnings
|
Expand Research on TMO
| Next EPS Date | 10/28/26 | EPS Growth Rate | +10.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +4.0% | Revenue Growth Rate | +7.5% |
| Average % Move 1-Wk after EPS | -1.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/28/26  |
Q326 | N/A | $6.41 | N/A | N/A | $11.95B | N/A | N/A | N/A | ||
| 7/23/26 | Q226 | $6.03 | $5.72 | +$0.31 | $11.99B | $11.71B | N/A |  | | Details | |
| 4/23/26 | Q126 | $5.44 | $5.25 | +$0.19 | $11.01B | $10.87B | N/A | | | Details | |
| 1/29/26 | Q425 | $6.57 | $6.45 | +$0.12 | $12.21B | $11.89B | N/A | | | Details | |
| 10/22/25 | Q325 | $5.79 | $5.50 | +$0.29 | $11.12B | $10.91B | N/A | | | Details | |
| 7/23/25 | Q225 | $5.36 | $5.23 | +$0.13 | $10.85B | $10.68B | N/A | | | Details | |
| 4/23/25 | Q125 | $5.15 | $5.11 | +$0.04 | $10.36B | $10.23B | N/A | | | Details | |
| 1/30/25 | Q424 | $6.10 | $5.95 | +$0.15 | $11.4B | $11.29B | N/A | | | Details |
